Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/130.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material
Description: Subject matter involving an immunoglobulin, an antiserum, an antibody, or an antibody fragment, except a conjugate or a complex of the same with a nonimmunoglobulin material.

Sub-classes under this class:

Class Number Class Name Patents
424/131.1 Anti-idiotypic 164
424/171.1 Binds allergen or component thereof 24
424/139.1 Binds antigen or epitope whose amino acid sequence is disclosed in whole or in part (e.g., binds specifically-identified amino acid sequence, etc.) 1,179
424/163.1 Binds antigens of multiple bacterial species (e.g., multivalent antiserum that binds antigens of multiple bacterial species, etc.) 58
424/164.1 Binds bacterium or component thereof or substance produced by said bacterium 300
424/172.1 Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell (e.g., honey, etc.) 329
424/138.1 Binds expression product or fragment thereof of cancer-related gene (e.g., oncogene, proto-oncogene, etc.) 569
424/175.1 Binds hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., drug, etc.) 68
424/158.1 Binds hormone or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., cytokine, vascular permeability factor, etc.); or binds serum protein, plasma protein, fibrin, or enzyme 578
424/137.1 Binds specifically-identified oligosaccharide structure 166
424/159.1 Binds virus or component thereof 194
424/132.1 Derived from transgenic multicellular eukaryote (e.g., plant, etc.) 45
424/157.1 Derived from, or present in, food product (e.g., milk, colostrum, whey, eggs, etc.) 128
424/140.1 Extracorporeal or ex vivo removal of antibodies or immune complexes (e.g., removal of autoantibodies, etc.); or extracorporeal or ex vivo removal of antigen by antibodies (e.g., removal of cancer cells from bone marrow by antibodies, etc.) 115
424/176.1 Free from infectious agents (e.g., viruses or bacteria removed or inactivated, etc.) 95
424/141.1 Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) 2,193
424/177.1 Reduced antigenicity, reduced ability to bind complement, or reduced numbers of activated complement components (e.g., free from aggregated, denatured, fragmented, or polymerized immunoglobulins; free from proteolytic enzymes, etc.) 141
424/133.1 Structurally-modified antibody, immunoglobulin, or fragment thereof (e.g., chimeric, humanized, cdr-grafted, mutated, etc.) 2,292

Patents under this class:

Patent Number Title Of Patent Date Issued
8710202 Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity Apr. 29, 2014
8709425 Antibodies to non-functional P2X.sub.7 receptor Apr. 29, 2014
8709418 Pharmaceutical composition for treating CAPRIN-1 expressing cancer Apr. 29, 2014
8709417 Combination immunotherapy for the treatment of cancer Apr. 29, 2014
8709416 Compositions of PD-1 antagonists and methods of use Apr. 29, 2014
8709415 Antibodies to OX-2/CD200 and uses thereof Apr. 29, 2014
8709414 Superagonistic anti-CD28 antibodies Apr. 29, 2014
8709413 Treatment of celiac disease with IgA Apr. 29, 2014
8709412 Modulation of TIM receptor activity in combination with cytoreductive therapy Apr. 29, 2014
8709411 Combination therapy to enhance NK cell mediated cytotoxicity Apr. 29, 2014
8709409 Method for treating rheumatoid arthritis by administering an anti-IL-6 antibody and methotrexate Apr. 29, 2014
8703920 Fully human antibodies against N-cadherin Apr. 22, 2014
8703712 Targeting cancer stem cells with DR5 agonists Apr. 22, 2014
8703143 Antibodies of the ED-B domain of fibronectin, their construction and uses Apr. 22, 2014
8703141 Method for treating Crohn's disease by administering an anti-IL-12 antibody Apr. 22, 2014
8703138 Treatment of inflammatory diseases by inhibiting cold-inducible RNA-binding protein (CIRP) Apr. 22, 2014
8703130 Bispecific anti-VEGF/anti-ANG-2 antibodies Apr. 22, 2014
8703129 Antibodies against extended type 1 chain antigens, derivatives thereof and use Apr. 22, 2014
8703128 Methods of modulating TGF.beta. signaling Apr. 22, 2014
8703127 Methods and materials for the diagnosis of prostate cancers Apr. 22, 2014
8703126 Reduced-viscosity concentrated protein formulations Apr. 22, 2014
8703125 Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders Apr. 22, 2014
8703124 Combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system Apr. 22, 2014
8691224 Anti-A.beta. globulomer 5F7 antibodies Apr. 8, 2014
8691223 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof Apr. 8, 2014
8691222 NLRR-1 antagonists and uses thereof Apr. 8, 2014
8691221 Analgesic treatment with prolonged effect Apr. 8, 2014
8685932 Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases Apr. 1, 2014
8685400 Modulating inflammasome activity and inflammation in the central nervous system Apr. 1, 2014
8685398 Chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer Apr. 1, 2014
8685395 Methods of antagonizing signal transduction in dorsal root ganglion cells Apr. 1, 2014
8685394 Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases Apr. 1, 2014
8685393 Methods and compositions for the treatment and diagnosis of systemic anthrax infection Apr. 1, 2014
8680241 Humanized antibodies specific for HSP65-derived peptide-6 methods and uses thereof Mar. 25, 2014
8679785 Knobs and holes heteromeric polypeptides Mar. 25, 2014
8679762 Method of detecting hepatitis B virus s antigen Mar. 25, 2014
8679540 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications Mar. 25, 2014
8679489 Inhibiting cell migration Mar. 25, 2014
8679488 Targeting of bone marrow neovasculature Mar. 25, 2014
8679487 Anti-interleukin-4 receptor antibodies Mar. 25, 2014
8679486 High-potency botulinum toxin formulations Mar. 25, 2014
8679485 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis Mar. 25, 2014
8679484 Method for removal of toxins from mucosal membranes Mar. 25, 2014
8679483 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine Mar. 25, 2014
8679471 Modulation of regulatory T cells by human IL-18 Mar. 25, 2014
8674079 Cancer cell migration and cancer cell invasion inhibitor Mar. 18, 2014
8674078 Methods of using BTL-II proteins Mar. 18, 2014
8673581 sCD40L and placental growth factor (PLGF) as biochemical marker combinations in cardiovascular diseases Mar. 18, 2014
8673309 Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1 Mar. 18, 2014
8673308 Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseases Mar. 18, 2014

  Recently Added Patents
Sensor coating
Anti-FGFR3 antibodies and methods using same
Molded surface of a concrete product
Secure provisioning of a portable device using a representation of a key
Method and apparatus for connecting to external device
Wrench head
Light-emitting device package and method of manufacturing the same
  Randomly Featured Patents
Method and arrangement for melting charges, particularly for use in the production of steel
Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
Safety braking apparatus for a portable chain saw
Storage battery
Non-volatile semiconductor memory device
Digital delay lines
Toy electronic cooking stove
Locking support arrangement for a flexible sound-generating diaphragm
Closed mode user interface for wireless communication devices